Associate Professor Borislava Mihaylova
Borislava Mihaylova
MSc, DPhil
Associate Professor
- Health Economics Research Centre
Borislava (Boby) Mihaylova is an Associate Professor and Senior Health Economist at the Health Economics Research Centre at the University of Oxford.
Her research programme focuses on economic aspects of chronic disease (such as cardiovascular, chronic kidney disease and diabetes) and comprises studies of the impact of disease events and interventions on morbidity, mortality, health-related quality of life and healthcare costs; development of disease models to evaluate long-term effects of disease and interventions, cost-effectiveness analyses of healthcare interventions and studies of socio-economic determinants of health.
She is leading the development of the economic analyses in a number of large randomised controlled trials (SHARP, THRIVE, REVEAL and ACST-2) and in the individual participant data meta-analysis of statin trials (Cholesterol Treatment Collaboration).
Her work on effectiveness and cost-effectiveness of statins for cardiovascular disease prevention in the Heart Protection Study and the Cholesterol Treatment Collaboration has been influential in informing treatment recommendations for people at different vascular disease risk.
Recent publications
-
Impact of pain, fatigue and bowel incontinence on the quality of life of people living with inflammatory bowel disease: A UK cross-sectional survey.
Roukas C. et al, (2024), United European Gastroenterol J
-
Children's Health in London and Luton (CHILL) cohort: a 12-month natural experimental study of the effects of the Ultra Low Emission Zone on children's travel to school.
Xiao C. et al, (2024), Int J Behav Nutr Phys Act, 21
-
2024 ESC Guidelines for the management of peripheral arterial and aortic diseases.
Mazzolai L. et al, (2024), Eur Heart J
-
2024 ESC Guidelines for the management of elevated blood pressure and hypertension.
McEvoy JW. et al, (2024), Eur Heart J
-
2024 ESC Guidelines for the management of chronic coronary syndromes.
Vrints C. et al, (2024), Eur Heart J